Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for severe pulmonary inflammation in children with acute respiratory distress syndrome
RBR-96kvrqPhase 2Recruiting
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of methylprednisolone in acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) (2 arms), sponsored by Instituto D’Or de Pesquisa e Ensino. Started Feb 2015; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
acute respiratory distress syndrome (ARDS)acute lung injury (ALI)
Beyond the preview
Go deeper on RBR-96kvrq.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-96kvrq.